Bayer recruits oncology vet Christine Roth from GSK to lead oncology business unit
Bayer has a new head of oncology in its pharmaceuticals division — and she comes from GSK.
Christine Roth, a former senior VP and head of oncology at GSK, will be leading Bayer’s oncology strategic business unit while based in the US, the pharma announced. And she’s arriving on the heels of new Phase III data that could give their cancer blockbuster hopeful Nubeqa a better shot at marketing glory.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.